CShah Satnam Ji Speciality Hospitals, Sirsa, Haryana, India.
Glaucoma Services, Fortis Memorial Research Institute, Gurugram, Haryana, India.
Rom J Ophthalmol. 2020 Apr-Jun;64(2):85-95.
The challenges of glaucoma management are many: the disease is chronic, progressive, often asymptomatic, and very often, the quality of life and costs of treatment is unacceptable to the patient. This is true for both medical therapy and conventional glaucoma surgery. The choice of therapy, especially the transition from the former to the latter, is now being bridged by Minimally Invasive Glaucoma Surgeries (MIGS). Choosing from the several options now available in the surgical armamentarium requires a deeper understanding of the available modalities. This review aims to provide an overview of the decision-making process, keeping in mind age, type of glaucoma, life expectancy, socioeconomic status, patient expectations, and coexisting cataract.
该病呈慢性、进展性，通常无症状，而且治疗的生活质量和费用往往让患者难以接受。这既适用于药物治疗，也适用于传统的青光眼手术。现在，微创青光眼手术 (MIGS) 正在弥合这一差距，使治疗选择，尤其是从前者向后者的转变成为可能。在手术工具包中可供选择的几种方法中进行选择，需要更深入地了解可用的方法。本文旨在概述决策过程，同时考虑到年龄、青光眼类型、预期寿命、社会经济状况、患者期望和并存白内障。
